نتائج البحث

Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib

• Authors : National Cancer Institute (NCI)

• Source: Ponatinib as Second Line Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or

تفاصيل العنوان

Dasatinib in Treating Patients With Early Chronic Phase Chronic Myelogenous Leukemia

• Authors : National Cancer Institute (NCI)

• Source: Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) With Dasatinib (BMS-354825)Jain P,

تفاصيل العنوان

Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid Leukemia

• Authors : National Cancer Institute (NCI)

• Source: Stopping Tyrosine Kinase Inhibitors (TKI) to Assess Treatment-Free Remission (TFR) in Pediatric Chronic Myeloid Leukemia - Chronic

تفاصيل العنوان

Dasatinib and Venetoclax in Treating Patients With Philadelphia Chromosome Positive or BCR-ABL1 Positive Early Chronic Phase Chronic Myelogenous Leukemia

• Authors : National Cancer Institute (NCI)

• Source: Therapy of Early Chronic Phase Chronic Myelogenous Leukemia (CML) With Dasatinib and Venetoclax: A

تفاصيل العنوان

ASTX727 and Dasatinib for the Treatment of Newly Diagnosed Philadelphia Chromosome or BCR-ABL Positive Chronic Myeloid Leukemia in Chronic Phase

• Authors : National Cancer Institute (NCI); Astex Pharmaceuticals, Inc.

• Source: Phase II Study Assessing Safety and Clinical Activity of the Combination of ASTX727 With Dasatinib in Patients With Newly Diagnosed

تفاصيل العنوان

Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia

• Authors : Erasmus Medical Center; Dutch Childhood Oncology Group; Innovative Therapies for Children with Cancer

• Source: A Phase I/II Study of Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or

تفاصيل العنوان

Frontline Asciminib Combination in Chronic Phase CML (CMLXI)

• Authors : Ludwig-Maximilians - University of Munich; Novartis Pharmaceuticals; Thomas Ernst, PD Dr. med., Principal Investigator

• Source: Frontline Asciminib Combination in Chronic Phase CML

تفاصيل العنوان

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML) or With Ph+ Leukemias Resistant or Intolerant to Imatinib

• Source: A Phase II Study of Dasatinib Therapy in Children and Adolescents With Newly Diagnosed Chronic Phase

تفاصيل العنوان

Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia

• Authors : Novartis

• Source: Phase II Study of Asciminib for Second-line Treatment of Chronic Phase

تفاصيل العنوان

Loss in Overall and Quality-Adjusted Life Expectancy for Patients With Chronic-Phase Chronic Myeloid Leukemia

• Authors : Chen, EY-T; Dahlen, T; Stenke, L

• Source: EUROPEAN JOURNAL OF HAEMATOLOGY. 114(2):334-342

تفاصيل العنوان